Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
03.05. | Why Alignment Healthcare, Inc. (ALHC) Went Down On Friday | 1 | Insider Monkey | ||
01.05. | Alignment Healthcare, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
01.05. | Alignment Healthcare Reports Strong First Quarter 2025 Results; Exceeds High-End of Expectations On 4 Critical KPIs; Raises Midpoint of 2025 Guidance; Announces CFO Transition | 1.039 | GlobeNewswire (Europe) | Delivers Q1 revenue of $926.9 million, up 47.5% year over year, and grows Medicare Advantage (MA) membership by 31.7% to approximately 217,500 membersExceeds high-end of Q1 guidance on membership... ► Artikel lesen | |
ALIGNMENT HEALTHCARE Aktie jetzt für 0€ handeln | |||||
01.05. | Alignment Healthcare, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
15.04. | Alignment Healthcare, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
09.04. | Alignment Healthcare Hits 54th 52-Week High: Does It Have What It Takes to Keep Winning? | 1 | Barchart.com | ||
09.04. | Why Alignment Healthcare Inc. (ALHC) Surged On Tuesday? | 1 | Insider Monkey | ||
08.04. | Stifel raises Alignment Healthcare target to $23, maintains Buy | 3 | Investing.com | ||
08.04. | Stifel raises Alignment Healthcare target to $23 on CMS rate notice | 1 | Investing.com | ||
24.03. | Alignment Healthcare for Seniors | 2 | Barchart.com | ||
04.03. | Piper Sandler raises Alignment Healthcare target to $21, keeps Overweight | 2 | Investing.com | ||
03.03. | Raymond James lifts Alignment Healthcare target to $19 | 3 | Investing.com | ||
03.03. | Alignment Healthcare, Inc. (NASDAQ:ALHC) Q4 2024 Earnings Call Transcript | 2 | Insider Monkey | ||
28.02. | Alignment Healthcare posts $701M in quarterly revenue, beats expectations | 2 | FierceHealthcare | ||
27.02. | Alignment Healthcare Reports Fourth Quarter and Full-Year 2024 Results; Provides Full-Year 2025 Financial Guidance | 495 | GlobeNewswire (Europe) | Reports 189,100 health plan members as of Dec. 31, 2024, up 58.6% year-over-year, beating year-end expectationsAchieves first full year of positive adjusted EBITDA as a public company, driven by operating... ► Artikel lesen | |
27.02. | Alignment Healthcare, Inc. - 10-K, Annual Report | - | SEC Filings | ||
27.02. | Alignment Healthcare, Inc. - 8-K, Current Report | - | SEC Filings | ||
24.02. | Alignment Healthcare Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) | 1 | Benzinga.com | ||
27.01. | Alignment Healthcare - A Tech-enabled Medicare Advantage Company | 3 | Barchart.com | ||
17.01. | Alignment Healthcare is latest to sue Medicare over Star Ratings | 5 | Seeking Alpha |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
UNITEDHEALTH | 258,95 | -6,11 % | UnitedHealth Group-Aktie leicht im Minus (338,6583 €) | Im US-amerikanischen Wertpapierhandel liegt die Aktie der UnitedHealth Group gegenwärtig im Minus. Die Aktie notiert derzeit bei 381,59 US-Dollar. Die UnitedHealth Group-Aktie verzeichnet aktuell ein... ► Artikel lesen | |
INCANNEX HEALTHCARE | 0,671 | 0,00 % | Incannex Healthcare (IXHL) Stock Soars Over 800%: What's Going On? | ||
FRESENIUS | 41,910 | +0,34 % | BERENBERG stuft Fresenius SE auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Fresenius von 45 auf 50 Euro angehoben und die Einstufung auf "Buy" belassen. Nach dem starken Jahresstart der Aktie hätten... ► Artikel lesen | |
BRIGHTSPRING HEALTH SERVICES | 23,480 | +1,03 % | IPO Stock Of The Week: Health Care Leader BrightSpring Poised To Hit New Buy Point | ||
NUTEX HEALTH | 158,61 | +25,95 % | Nutex Health, Inc.: Nutex Health Reports First Quarter 2025 Financial Results | TOTAL REVENUE OF $211.8 MILLION VERSUS $67.5 MILLION IN Q1 2024, AN INCREASE OF 213.8%
NET INCOME ATTRIBUTABLE TO NUTEX HEALTH INC. OF $14.6 MILLION VERSUS NET... ► Artikel lesen | |
GENEDX | 59,51 | 0,00 % | GeneDx Holdings stock trades higher as upgraded at Jefferies | ||
SIEMENS HEALTHINEERS | 47,980 | -0,35 % | GOLDMAN SACHS stuft Siemens Healthineers auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Siemens Healthineers von 60 auf 56 Euro gesenkt, aber die Einstufung auf "Neutral" belassen. Richard Felton passte... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 54,75 | +3,22 % | PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2024 Results | SAN JOSE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
BASEL MEDICAL GROUP | 1,640 | 0,00 % | Basel Medical Group Ltd: Basel Medical Group Completes Acquisition of Bethesda Medical to Strengthen Healthcare Ecosystem in Singapore and Southeast Asia | Singapore, April 30, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL), today announced the closing of the acquisition of Bethesda Medical Pte. Ltd., a leading Singapore-based healthcare... ► Artikel lesen | |
HIMS & HERS HEALTH | 53,20 | -2,85 % | Hims & Hers Stock Pulls Back After Strong Q1 Earnings, 115% Gain Over Past Month | ||
AVEANNA HEALTHCARE | 5,820 | -0,94 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces First Quarter Financial Results and Revised 2025 Outlook | First Quarter Revenue was $559.2 million, a 14.0% increase over the prior year period Gross margin increased 25.9% to $183.6 million compared to Q1 2024 First Quarter Net income was $5.2 million compared... ► Artikel lesen | |
PROGYNY | 21,860 | 0,00 % | Progyny erweitert Medizinischen Beirat um zwei renommierte Ärztinnen | ||
LIFEMD | 9,560 | 0,00 % | LifeMD, Inc.: LifeMD Reports Fourth Quarter 2024 Results | Consolidated revenues increased 43% year-over-year to $64.3 million with telehealth revenue up 60%Adjusted EBITDA increased 78% to $9.0 millionTelehealth adjusted EBITDA increased 396% to $5.9 millionFull-year... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 50,42 | +0,84 % | Fresenius Medical Care: Analysten pessimistisch - Die Kasse klingelt! | ||
ATRICURE | 32,220 | +2,35 % | AtriCure Q1 2025 presentation: Revenue up 13.6%, raises full-year guidance |